首页> 外文期刊>Biopharmaceutics and Drug Disposition >Pharmacokinetic modelling of the plasma concentration‐time profile of the vitamin retinyl palmitate following intramuscular administration
【24h】

Pharmacokinetic modelling of the plasma concentration‐time profile of the vitamin retinyl palmitate following intramuscular administration

机译:肌内给药后维生素视黄醇棕榈酸酯血浆浓度-时间曲线的药代动力学建模

获取原文
获取外文期刊封面目录资料

摘要

AbstractSeven healthy male volunteers (21–24 y) received by the ventro‐gluteal route a single dose of 100 000 I.U. of the vitamin retinyl palmitate (RP) in a water‐miscible preparation (W) and 5 weeks later the same dose in an oily solution (S). After administration of W median (range) peak plasma concentrations of 5.6(4.4–8.7). 103μg 1‐−1were reached after 12 h and high levels persisted for another 50 h. At 144 h levels were still, by a factor 3, higher than baseline. Plasma levels of RP after S remained close to baseline (20–50 μg.1−1) suggesting negligibly low bioavailability. The plasma level profile of RP after W could well be described by use of a one‐compartment model with Weibull‐type absorption and Michaelis‐Menten elimination. The median (range) absolute bioavailability (estimates of lower limits)
机译:摘要7名健康男性志愿者(21-24岁)通过腹臀途径接受单剂量100 000 IU的维生素棕榈酸视黄酯(RP)水溶性制剂(W),5周后接受相同剂量的油性溶液(S)。施用W后,血浆中位数(范围)峰值浓度为5.6(4.4-8.7)。12 h后达到103μg1‐−1,高水平持续50 h。在144小时时,水平仍比基线高出3倍。S 后血浆 RP 水平仍接近基线 (20–50 μg.1−1),表明生物利用度低可忽略不计。W后RP的血浆水平曲线可以通过使用具有Weibull型吸收和Michaelis-Menten消除的单室模型来描述。中位数(范围)绝对生物利用度(下限估计值)

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号